A new market study, titled “Global Anti-Obesity Therapeutics Market Research Report 2018”, has been featured on WiseGuyReports.
This report studies the global Anti-Obesity Therapeutics market status and forecast, categorizes the global Anti-Obesity Therapeutics market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
Anti-obesity drugs are the drugs that help in reducing or controlling body mass, either by decreasing the craving or increasing the consumption of calories. Appetite control is achieved through the use of agonists for appetite suppressing pathways.
Geographically, North America captures the largest market share on account of increasing obese population. As per the historical trends, more than one-third of the U.S. population is obese. However, Asia Pacific is anticipated to grow at the fastest rate due to increasing demand for the drugs and awareness about the risk associated with obesity. According to WHO, 13.0% of the population were obese in 2014. In developing countries the rate of childhood obesity is increasing and has been 30.0% higher than that of developed countries.
The major manufacturers covered in this report
Bristol-Myers Squibb
Eisai Company
FlaxoSithKline plc.
Novo Nordisk
Alizyme
BoehringerIngelheim GmbH
Pfizer
Takeda Pharmaceutical
Rhythm Pharmaceuticals
Shionogi USA
Vivus
Zafgen
Norgine Pharmaceuticals Ltd.
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
North America
Europe
China
Japan
Southeast Asia
India
Request Sample Report at https://www.wiseguyreports.com/sample-request/3317081-global-anti-obesity-therapeutics-market-research-report-2018
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Centrally Acting Anti-obesity Drugs
Peripherally Acting Anti-obesity Drugs
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Hospital Use
Clinic Use
Household
Other
The study objectives of this report are:
To analyze and study the global Anti-Obesity Therapeutics sales, value, status (2013-2017) and forecast (2018-2025).
Focuses on the key Anti-Obesity Therapeutics manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Anti-Obesity Therapeutics are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered
Key Stakeholders
Anti-Obesity Therapeutics Manufacturers
Anti-Obesity Therapeutics Distributors/Traders/Wholesalers
Anti-Obesity Therapeutics Subcomponent Manufacturers
Industry Association
Downstream Vendors
Table of Contents
1 Anti-Obesity Therapeutics Market Overview
2 Global Anti-Obesity Therapeutics Market Competition by Manufacturers
3 Global Anti-Obesity Therapeutics Capacity, Production, Revenue (Value) by Region (2013-2018)
4 Global Anti-Obesity Therapeutics Supply (Production), Consumption, Export, Import by Region (2013-2018)
5 Global Anti-Obesity Therapeutics Production, Revenue (Value), Price Trend by Type
6 Global Anti-Obesity Therapeutics Market Analysis by Application
7 Global Anti-Obesity Therapeutics Manufacturers Profiles/Analysis
8 Anti-Obesity Therapeutics Manufacturing Cost Analysis
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
11 Market Effect Factors Analysis
12 Global Anti-Obesity Therapeutics Market Forecast (2018-2025)
13 Research Findings and Conclusion
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
